Header Logo

Connection

David Gordon to Clostridium Infections

Back to Details
This is a "connection" page, showing publications David Gordon has written about Clostridium Infections.
David Gordon
Connection Strength
0.163
Clostridium Infections
  1. Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial. Lancet Infect Dis. 2021 02; 21(2):252-262.
    View in: PubMed
    Score: 0.163
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.